Advancing the early detection of curable cancers
Applying Genetic Cytology to routinely collected patient samples
Founded by world leading cancer researchers from Johns Hopkins University,
we are commercializing advanced molecular tests for the early detection of cancers
by applying innovative massively parallel sequencing techniques
to routinely collected cytology samples.
PapGene is always interested in hearing from qualified personnel interested in joining our team, particularly from those with experience in massively parallel sequencing, bioinformatics, or high-complexity CLIA testing.
Interested candidates should e-mail a cover letter and their resume to hr@PapGeneInc.com.